Article: Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.

SHENZHEN, China, Nov. 5 /PRNewswire-Asia/ -- Shenzhen Beike Biotechnology Co. Ltd. ( http://www.beikebiotech.com/ ), China's leading stem cell research and regenerative medicine company, announced that it has entered into an agreement with Yokohama-based Biomaster Inc. ( http://www.biomaster.jp/ ) for investment in its advanced technologies. Biomaster specializes in research and commercialization of adipose-based stem cell therapies. Beike, along with two investment companies, has taken a significant share in Biomaster, secured a seat on the board, and is involved in the company's strategic positioning in preparation for an eventual IPO.

Since its inception in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!